Acyclovir Almost Ineffective Against Herpes Outbreaks; polyDNA Reviews the Medical Evidence - FOX 21/27 WFXR Roanoke/WWCW Lynchburg News, Weather

Acyclovir Almost Ineffective Against Herpes Outbreaks; polyDNA Reviews the Medical Evidence

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

Acyclovir modestly improved healing time and duration of pain by as much as half a day, according to the Journal of Family Practice in a study published in February, 2014. (1) polyDNA recommends two natural HSV remedies against the latent HSV.

Rochester, NY (PRWEB) July 18, 2014

Infected with the herpes virus? We recommend taking Novirin or Gene-Eden-VIR. Greg Bennett, CBCD

Most people are prescribed a topical medication as a treatment for their herpes outbreaks. However, a review of the medical literature by Dr. Eiko Tubridy and colleagues, shows that Two trials demonstrated that topical acyclovir (5% cream) modestly improved healing time and duration of pain (by as much as half a day). (1) The improvement was modest even though the treatment began immediately after the first signs of the outbreak. Patients in the first trial began treatment within an hour of prodromal symptoms or signs (warning signs that appear before the actual outbreak), applying the medication 5 times daily for 4 days. (1) In other words, topical acyclovir reduced the actual time it took for symptoms to disappear by only 12 hours! Dr. Tubridy is from the Valley Family Residency Program, Renton, Washington.

Click to learn more about herpes symptoms.

polyDNA therefore recommends that people infected with a herpes virus (HSV-1 or HSV-2) take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HSV, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, individuals infected with the (herpes and other viruses)reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR. (2) The study authors also wrote that, We observed a statistically significant decrease in the severity, duration, and frequency of symptoms. (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

The results of the review by Dr. Tubridy agree with the findings of Hanan Polansky and Edan Itzkovitz. In their paper, they wrote that Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. How- ever, their effectiveness is limited. For instance, a meta- analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day. (2)

Infection with HSV can cause pain and blistering within the mouth (gingivostomatitis or recurrent oral ulceration) or on or around the lips (cold sores or herpes labialis) herpes simplex virus type 1 (HSV-1) is usually the cause of oral infection. After primary infection, HSV-1 becomes latent, usually in the dorsal root ganglia of the trigeminal nerve. (See Patient.co.uk, Last reviewed on October 15, 2013) (3)

We recommend that individuals infected with the herpes virus use Novirin or Gene-Eden-VIR to target the latent HSV. - Mike Evans, polyDNA

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured. To speak to a polyDNA scientist, or to request an interview, call 585-250-9999 or E-mail note(at)buy-gene-eden(dot)com.

Click to read more about Novirin and the herpes virus, or Gene-Eden-VIR and the herpes virus.

References:

(1)    Eiko Tubridy, MD; Gary Kelsberg, MD Which drugs are most effective for recurrent herpes labialis? J Fam Pract. 2014 February;63(2):104-105.
(2)    Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
(3)    Patient.co.uk - Herpes Simplex Oral. Last reviewed on October 15, 2013.

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12025784.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.